124 results on '"Uro-Coste, Emmanuelle"'
Search Results
2. Les tumeurs des glandes salivaires associées à des transcrits de fusion
3. Muscular phenotype description of abnormal THOC2 splicing
4. Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status
5. Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial)
6. Liste des collaborateurs
7. Hypofractionated Stereotactic Re-irradiation and Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results
8. Data from Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation
9. Neurosphere formation_PST3.1a-treated from Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation
10. Supplementary Figure S1 from Clinical Response of Carcinomas Harboring the BRD4–NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628
11. Data from Clinical Response of Carcinomas Harboring the BRD4–NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628
12. Supplementary figures 1 to 6 from Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation
13. Data from Clinical Response of Carcinomas Harboring the BRD4–NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628
14. Data from Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation
15. Neurosphere formation_control from Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation
16. Neurosphere formation_PST3.1a-treated from Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation
17. Supplementary Figure S1 from Clinical Response of Carcinomas Harboring the BRD4–NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628
18. Neurosphere formation_control from Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation
19. Supplementary figures 1 to 6 from Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation
20. Supplementary Methods, Tables S1 - S2 from Clinical Response of Carcinomas Harboring the BRD4–NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628
21. Supplementary Methods, Tables S1 - S2 from Clinical Response of Carcinomas Harboring the BRD4–NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628
22. Survival outcomes, prognostic factors, and effect of adjuvant radiotherapy and prophylactic neck dissection in salivary acinic cell carcinoma: A prospective multicenter REFCOR study of 187 patients
23. Corrigendum: Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report
24. Natural Course and Prognosis of Primary Spinal Glioblastoma: A Nationwide Study
25. Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report
26. Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours
27. PATH-12. A new powerful tool to simultaneously deliver DNA methylation profile and driver fusions detection based on Nanopore Sequencing
28. Évolution métastatique et réponse au traitement anti-FGFR d’un astrocytome de haut grade présentant un nouveau transcrit de fusion FGFR1-GNE
29. Rosette‐forming glioneuronal tumours are midline, FGFR1‐mutated tumours
30. Molecular and clinical diversity in primary central nervous system lymphoma: a LOC Network study
31. A recurrent RYR1 mutation associated with early-onset hypotonia and benign disease course
32. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum
33. An Integrated Clinical-Biological Approach to Identify Interindividual Variability and Atypical Phenotype-Genotype Correlations in Myopathies: Experience on A Cohort of 156 Families
34. Novel dominant distal titinopathy phenotype associated with copy number variation
35. Mucoepidermoid carcinoma of salivary glands: A French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases
36. Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic Options
37. Evaluating next-generation sequencing in neuromuscular diseases with neonatal respiratory distress
38. Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for IDH-Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA Cohort
39. Contribution of narrow band imaging in delineation of laryngopharyngeal superficial cancer spread: a prospective study
40. Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis
41. The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of “CNS tumors with BCOR internal tandem duplication”
42. The importance of an integrated genotype-phenotype strategy to unravel the molecular bases of titinopathies
43. Clinical phenotype and loss of the slow skeletal muscle troponin T in three new patients with recessive TNNT1 nemaline myopathy
44. What is hiding behind S100 protein and SOX10 positive oncocytomas? Oncocytic pleomorphic adenoma and myoepithelioma with novel gene fusions in a subset of cases
45. Translation reprogramming by eIF3 linked to glioblastoma resistance
46. Management of cN0 low‐grade mucoepidermoid carcinomas of salivary glands: Prospective multicentre study of 152 cases of the French Network of Rare Head and Neck Tumors (REFCOR)
47. Which Method for Diagnosing Small Fiber Neuropathy?
48. A prospective multicentre REFCOR study of 470 cases of head and neck Adenoid cystic carcinoma: epidemiology and prognostic factors
49. Amyloid-β transmission through cardiac surgery using cadaveric dura mater patch
50. The molecular landscape of ETMR at diagnosis and relapse
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.